Rapid test for the qualitative simultaneous determination of cardiac fatty acid-binding protein and cardiac troponin I in the diagnosis of acute coronary syndrome

Aim. To study the diagnostic characteristics of the rapid test for qualitative simultaneous determination of cardiac fatty acid-binding protein (FABPs) and cardiac troponin I (cTnI) CARD-INFO 1+1 in patients with acute coronary syndrome (ACS).

Material and methods. The study included 168 patients undergoing inpatient treatment after ACS, with typical anginal pain lasting at least 20 minutes occurred in the previous 1-24 hours. In addition to routine diagnostic procedures, on admission, we determined FABPs and cTnI concentrations using the high-quality immunochromatographic rapid test CARD-INFO 1 1 (OOO CARDIO-Plus, Russia).

Results. The sensitivity of the CARD-INFO 1+1 rapid test was 88,1%, specificity — 89,8%, diagnostic accuracy — 88,7%. The indicators of the diagnostic effectiveness of CARD-INFO 1+1 test in patients with STE-ACS and NSTE-ACS did not significantly differ (p>0,05). The sensitivity of the rapid test reached a maximum in the period from 3 to 6 hours from the onset of pain. Compared with the determination of cTnI performed on admission to the hospital, a higher sensitivity of the CARD-INFO 1+1 test was revealed in patients with STE-ACS (87,7% vs 75,3%; p=0,044), in the first 1-3 hours after the beginning of clinical manifestations (86,8% vs 60,5%; p=0,041) and in the entire sample as a whole (88,1% vs 77,1%; p=0,033), with comparable specificity (89,8% and 93,2%, respectively; p=0,741).

Conclusion. Qualitative immunochromatographic CARD-INFO 1+1 rapid test for the simultaneous determination of the content of FABPs and cTnI I is highly effective in the diagnosis of various forms of ACS. The highest diagnostic characteristics of the test were observed in patients in the early stages of the disease (the first 1-6 hours after the onset of pain). Carrying out the CARD-INFO 1+1 test revealed 12 MI cases more (11%) than the first determination of cTnI. Further studies will clarify the place of this technique in the modern algorithm for the management of patients with ACS and evaluate the possibility of using the rapid test in predicting the course of the disease.

1. Disease Burden and Mortality Estimates (2000-2016). World Health Organization. URL: https://www.who.int/healthinfo/global_burden_disease/estimates/en/ (accessed 24 Aug 2019).

2. Data on mortality by the causes of death in Russian Federation during the period JanuaryDecember 2018. Federal Service of Statistics. URL: http://www.gks.ru/free_doc/2018/demo/t3_3.xls (In Russ.)

3. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction. Eur Heart J. 2018;40(3):237-69. doi:10.1093/eurheartj/ehy462.

4. Odqvist M, Andersson PO, Tygesen H, et al. High-sensitivity troponins and outcomes after myocardial infarction. J Am Coll Cardiol. 2018;71(23):2616-24. doi:10.1016/j.jacc.2018.03.515.

5. Shah ASV, Anand A, Strachan FE, et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet. 2018;392(10151):919-28. doi:10.1016/S0140-6736(18)31923-8.

6. Kleine AH, Glatz JF, van Nieuwenhoven FA, et al. Release of heart fatty acid-binding protein after acute myocardial infarction in man. Mol Cell Biochem. 1992;116:155-62. doi:10.1007/bf01270583.

7. Dupuy AM, Cristol JP, Kuster N, et al. Performances of the heart fatty acid protein assay for the rapid diagnosis of acute myocardial infarction in ED patients. Am J Emerg Med. 2015;33(3):326-30. doi:10.1016/j.ajem.2014.11.012.

8. Body R, Dixon D, Burrows G, et al. Economic evaluation of a heart-type fatty acid binding protein based protocol for rapid chest pain assessment. 14th International Conference on Emergency Medicine. Acad Emerg Med. 2012;19(6):746-7. doi:10.1111/j.15532712.2012.01372.x.

9. McMahon CG, Lamont JV, Curtin E, et al. Diagnostic accuracy of heart-type fatty acidbinding protein for the early diagnosis of acute myocardial infarction. Am J Emerg Med. 2012;30(2):267-74. doi:10.1016/j.ajem.2010.11.022.

10. Jacobs LH, van Borren M, Gemen E, et al. Rapidly rule out acute myocardial infarction by combining copeptin and heart-type fatty acid-binding protein with cardiac troponin. Ann Clin Biochem. 2015;52(Pt 5):550-61. doi:10.1177/0004563215578189.

11. Gami BN, Patel DS, Haridas N, et al. Utility of heart-type fatty acid binding protein as a new biochemical marker for the early diagnosis of acute coronary syndrome. J Clin Diagn Res. 2015;9(1):BC22-4. doi:10.7860/JCDR/2015/11006.5451.

12. Schoenenberger AW, Stallone F, Walz B, et al. Incremental value of heart-type fatty acidbinding protein in suspected acute myocardial infarction early after symptom onset. Eur Heart J Acute Cardiovasc Care. 2016;5(2):185-92. doi:10.1177/2048872615571256.

13. Liou K, Ho S, Ooi SY. Heart-type fatty acid binding protein in early diagnosis of myocardial infarction in the era of high-sensitivity troponin: a systematic review and meta-analysis. Ann Clin Biochem. 2015;52(Pt 3):370-81. doi:10.1177/0004563214553277.

14. Kokorin VA, Arefiev MN, Levchouk NN, et al. The first experience of clinical implementation of express-test for the qualitative simultaneous evaluation of cardiac protein, binding fatty acids, and cardiac troponin I in patients with suspected acute coronary syndrome. Therapy. 2019;1(27):36-42. (In Russ.) doi:10.18565/Терапия.2019;1[27]:36–42.

15. Thygesen K, Alpert JS, Jaffe AS, et al. Third Universal Definition of Myocardial Infarction. Eur Heart J. 2012;33:2551-67. doi:10.1093/eurheartj/ehs184.